The Lancet Respiratory Medicine in conversation with
Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.
A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COVID outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.
Podcasting since 2020 • 56 episodes
The Lancet Respiratory Medicine in conversation with
Latest Episodes
Toby Maher on ENV-101 in patients with idiopathic pulmonary fibrosis
Toby Maher joins us to discuss results of a randomised, double-blind, placebo-controlled, proof-of-concept trial of ENV-101, an oral inhibitor of the hedgehog signalling pathway, in patients with idiopathic pulmonary fibrosis.Read the fu...
•
9:26
Guy Brusselle and Celeste Porsbjerg on State-of-the-art insights into prevention, development, and management of asthma
Professors Guy Brusselle and Celeste Porsbjerg join us to discuss their recent Series papers on asthma, which will be featured in a cross journal project with The Lancet, published to coincide with a Lancet journal session on ...
•
22:43
Joan Soriano on Global Epidemiology of Respiratory Disease
Diana Stanley, Deputy Editor at The Lancet Respiratory Medicine, is joined by Dr Joan Soriano to discuss a new series on the global epidemiology of respiratory disease, exploring the diagnostic challenges, global trends, and future dir...
•
10:31
Carole Mitnick & Lorenzo Guglielmetti on the ENDTB-Q trial
Carole Mitnick & Lorenzo Guglielmetti join Ari Colosio, deputy editor of The Lancet Respiratory Medicine, to discuss the ENDTB-Q trial to evaluate the efficacy and safety of a drug regiment to treat TB in individuals with pre-exten...
•
18:45
Lorenzo Guglielmetti parla del trial clinico ENDTB-Q (in Italian)
This episode is in Italian. For the English version, please see the main feed.Lorenzo Guglielmetti sul trial clinico ENDTB-Q per valutare l’efficacia e la sicurezza di un regime di farmaci per curare la tubercolosi in individui co...
•
14:54